NFATC1 and neoplasm: Consistent with our findings depicted in Fig. 2, these data imply that NFATc1 controls transcription of pro-proliferative target genes that are strongly linked to a poor prognosis of PDAC patients and demonstrate that NFATc1 compromises the execution of predominantly tumor-suppressive TGFβ-dependent transcription programs in PDAC cells.